4.7 Article

Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation

Journal

JOURNAL OF NEUROSCIENCE
Volume 27, Issue 23, Pages 6128-6140

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.0296-07.2007

Keywords

histone deacetylase inhibitors; hippocampus-dependent memory; CREB-binding protein; KIX domain; Nr4a1; Nr4a2

Categories

Funding

  1. NHLBI NIH HHS [T32 HL007953, HL07953] Funding Source: Medline
  2. NIA NIH HHS [AG00256, T32 AG000256] Funding Source: Medline
  3. NIGMS NIH HHS [T32 GM007517, GM07517] Funding Source: Medline
  4. NIMH NIH HHS [MH060244, F31 MH069136, R01 MH060244-07, R01 MH060244, MH069136] Funding Source: Medline

Ask authors/readers for more resources

Histone deacetylase (HDAC) inhibitors increase histone acetylation and enhance both memory and synaptic plasticity. The current model for the action of HDAC inhibitors assumes that they alter gene expression globally and thus affect memory processes in a nonspecific manner. Here, we show that the enhancement of hippocampus-dependent memory and hippocampal synaptic plasticity by HDAC inhibitors is mediated by the transcription factor cAMP response element-binding protein (CREB) and the recruitment of the transcriptional coactivator and histone acetyltransferase CREB-binding protein (CBP) via the CREB-binding domain of CBP. Furthermore, we show that the HDAC inhibitor trichostatin A does not globally alter gene expression but instead increases the expression of specific genes during memory consolidation. Our results suggest that HDAC inhibitors enhance memory processes by the activation of key genes regulated by the CREB: CBP transcriptional complex.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available